DISTRIBUTION OF THE LABELED [¹²³I] PEPTIDE-PROTEIN DRUG CELLEX IN RATS
Abstract
The aim of this work was to study the distribution of the labeled 123I peptide-protein drug Cellex in organs and tissues of rats after single intravenous injection and accumulation. After a single intravenous injection of radiolabeled [123I]Cellex it was found that the drug is characterized by rapid distribution into tissues and organs. The highest content of the drug in all organs and tissues was observed in 15 minutes after its administration. It was established that the drug penetrates the blood-brain barrier and about 6% of the drug accumulates in the brain, which is 10% of the total amount of the drug found in all organs in 15 minutes after administration.
About the Authors
I. N. UrakovaRussian Federation
O. N. Pozharitskaya
Russian Federation
V. J. Sukhov
Russian Federation
M. N. Makarova
Russian Federation
A. N. Shikov
Russian Federation
V. G. Makarov
Russian Federation
References
1. Pizova N. V., Sokolov M. A., Izmajlov I. A. Cellex in the treatment of patients with acute cerebrovascular accident: the results of a Russian multicenter comparative open clinical study // Journal of Neurology and Psychiatry. S. Korsakov. 2014. T. 114. № 5. P. 22-26.
2. Kulesh A. A., SHestakov V. V. Post-stroke cognitive impairment and the possibility of treatment with Cellex // Journal of Neurology and Psychiatry. S. S. Korsakov. 2016. T. 116. № 5. P. 38-42.
3. Register of Medicinal Products of Russia Radar. Available at: https://www.rlsnet.ru/tn_index_id_49945.htm (accessed 26.01.2018).
4. Federal Law 361-ФЗ “On Circulation of Medicines” dated April 12, 2010. Available at:https://rg.ru/2010/04/14/lekarstva-dok.html (accessed 26.01.2018).
5. Kuil J., Velders А. Н., Van Leeuwen F. W. В. Multimodal tumor-targeting peptides functionalized with both a radio- and a fluorescent-label // Bioconjugate Chem. 2010. V. 21. P. 1709-1719.
6. Kuil J., Buckle T., Oldenburg J., Yuan H., Borowsky A. D., Josephson L., Van Leeuwen F. W. Hybrid peptide dendrimers for imaging of chemokine receptor 4 (CXCR4) expression // Molecular pharmaceutics. 2011. V. 8. P. 2444-2453.
7. Kuchmij A. A., Efimov G. A., Nedospasov S. A. Metody molekulyarnoj vizualizacii in vivo // Biohimiya. 2012. T. 77. S. 1603-1620.
8. Granov A.M., Tyutin L.A., Stanzhevskij A.A., Kostenikov N.A., Panfilenko A.F. The development and introduction of new tumor-tropic radiopharmaceuticals into clinical practice is the most important aspect of using the achievements of nuclear medicine in the oncological clinic. Radiology and Treatment. 2012. № 4. C. 11-21.
9. Meikle S. R., Kench P., Kassiou M., Banati R. B. Small animal SPECT and its place in the matrix of molecular imaging technologies // Physics in medicine and biology. 2005. V. 50(22). P. R45-R61.
10. Khalil M. M., Tremoleda J. L., Bayomy T. B., Gsell W. Molecular SPECT Imaging: An Overview // International journal of molecular imaging. 2011. V. 2011. P. 15.
11. Van der Have F., Vastenhouw B., Ramakers R. M., Branderhorst W., Krah J. O., Ji C., Staelens S. G., Beekman F. J. U-SPECT-II: An ultra-highresolution device for molecular small-animal imaging // Journal of Nuclear Medicine. 2009. V. 50(4). P. 599-605.
12. Burvenich I. J., Schoonooghe S., Blanckaert P., Bacher K., Vervoort L., Coene E., Mertens N., De Vos F., Slegers G. Biodistribution and planar gamma camera imaging of (123)I- and (131)I-labeled F(ab’)(2) and Fab fragments of monoclonal antibody 14C5 in nude mice bearing an A549 lung tumor // Journal of Nuclear Medicine. 2007. V. 34. T. 3. P. 257-265.
13. Merkel O. M., Librizzi D., Pfestroff A., Schurrat T., Béhé M., Kissel T. In vivo SPECT and real-time gamma camera imaging of biodistribution and pharmacokinetics of siRNA delivery using an optimized radiolabeling and purification procedure // Bioconjugate chemistry. 2009. V. 20(1). P. 174-182.
14. Williams S. P. Tissue distribution studies of protein therapeutics using molecular probes: molecular imaging // AAPS J. 2012. V. 14. T. 3. P. 389-399.
15. Refai E., Jonsson C., Andersson M., Jacobsson H., Larsson S., Kogner P., Hassan M. Biodistribution of liposomal 131I-VIP in rat using gamma camera // Nuclear medicine and biology. 1999. V. 26(8). P. 931-936.
16. Nikolaus S., Larisch R., Wirrwar A., Jamdjeu-Nouné M., Antke C., Beu M., Müller H. W. [¹²³I]Iodobenzamide binding to the rat dopamine D receptor in competition with haloperidol and endogenous dopamine - an in vivo imaging study with a dedicated small animal SPECT // European journal of nuclear medicine and molecular imaging. 2005. V. 32 (11). P. 1305-1310.
17. Bao A., Phillips W.T., Goins B. et al. Potential use of drug carriedliposomes for cancer therapy via direct intratumoral injection // International Journal of Pharmaceutics. 2006. V. 316(1-2). P. 162-169.
18. Wang D., Sima M., Mosley R. L., Davda J. P., Tietze N., Miller S. C., Kopeček J. Pharmacokinetic and biodistribution studies of a bone-targeting drug delivery system based on N-(2-hydroxypropyl)methacrylamide Copolymers // Molecular Pharmaceutics. V. 3(6). P. 717-725.
19. Wolf H., Marschall F., Scheffold N., Clausen M., Schramm M., Henze E. Iodine-123 labelling of atrial natriuretic peptide and its analogues: initial results // European journal of nuclear medicine. 1993. V. 20(4). P. 297-301.
20. Severin S. E., Kulakov V. N., Moskaleva E. YU., Severin E. S., Slobodyanik I. I., Klimova T. P. Distribution of iodine-labeled-125 alpha-fetoprotein in the organism of animals and its accumulation in the tumor tissue // Herald of the Russian Academy of Medical Sciences. 2012. № 4. C. 11-15.
21. Bayrak E., Lambrecht F. Y., Durkan K., Yilmaz O. In vitro evaluation, biodistribution in rats of radiolabeled raloxifene // Applied radiation and isotopes. 2010. V. 68(1). P. 33-36.
Review
For citations:
Urakova I.N., Pozharitskaya O.N., Sukhov V.J., Makarova M.N., Shikov A.N., Makarov V.G. DISTRIBUTION OF THE LABELED [¹²³I] PEPTIDE-PROTEIN DRUG CELLEX IN RATS. Drug development & registration. 2018;(4):89-94. (In Russ.)